210 related articles for article (PubMed ID: 27031887)
1. Improving Prostate Cancer Screening and Diagnosis: Health Policy and Biomarkers Beyond PSA.
Patel HD; Chalfin HJ; Carter HB
JAMA Oncol; 2016 Jul; 2(7):867-8. PubMed ID: 27031887
[No Abstract] [Full Text] [Related]
2. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
3. [PSA and blood test diagnostics of prostate cancer].
Seikkula H; Pettersson K; Boström PJ
Duodecim; 2015; 131(17):1547-52. PubMed ID: 26548101
[TBL] [Abstract][Full Text] [Related]
4. [PSA 2010--the beginning of a new era in early detection of prostate cancer].
Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H
Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115
[No Abstract] [Full Text] [Related]
5. [Status of PSA determination for early detection of prostate carcinoma].
Hammerer P; Huland H
Versicherungsmedizin; 1995 Jun; 47(3):83-6. PubMed ID: 7541925
[TBL] [Abstract][Full Text] [Related]
6. Screening for Prostate Cancer-Beyond Total PSA, Utilization of Novel Biomarkers.
Morgan T; Palapattu G; Wei J
Curr Urol Rep; 2015 Sep; 16(9):63. PubMed ID: 26169584
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer: PSA velocity in prostate cancer screening--the debate continues.
Borofsky MS; Makarov DV
Nat Rev Urol; 2011 Jul; 8(8):413-4. PubMed ID: 21750502
[No Abstract] [Full Text] [Related]
8. PSA testing beneficial for prostate cancer.
Bagcchi S
Lancet Oncol; 2014 Sep; 15(10):e424. PubMed ID: 25328952
[No Abstract] [Full Text] [Related]
9. PHI in the Early Detection of Prostate Cancer.
Fuchsova R; Topolcan O; Windrichova J; Hora M; Dolejsova O; Pecen L; Kasik P; Novak J; Casova M; Smejkal J
Anticancer Res; 2015 Sep; 35(9):4855-7. PubMed ID: 26254378
[TBL] [Abstract][Full Text] [Related]
10. [Early diagnosis of prostate cancer].
Hocaoglu Y; Seitz M; Stief CG; Bastian PJ
MMW Fortschr Med; 2012 Jan; 154(1):43-6. PubMed ID: 22642003
[No Abstract] [Full Text] [Related]
11. Words of wisdom. Re: PSA density improves prediction of prostate cancer.
Roobol MJ
Eur Urol; 2014 Nov; 66(5):964-5. PubMed ID: 25763443
[No Abstract] [Full Text] [Related]
12. [Current results on PSA-based prostate cancer detection].
Graefen M; Schlomm T; Steuber T; Sauter G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):312-7. PubMed ID: 24562706
[TBL] [Abstract][Full Text] [Related]
13. Screening for prostate cancer in Dutch hereditary prostate cancer families.
Kiemeney LA; Broeders MJ; Pelger M; Kil PJ; Schröder FH; Witjes JA; Vasen HF
Int J Cancer; 2008 Feb; 122(4):871-6. PubMed ID: 17957791
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases.
Kang SH; Bae JH; Park HS; Yoon DK; Moon DG; Kim JJ; Cheon J
Int J Urol; 2006 Jul; 13(7):910-4. PubMed ID: 16882054
[TBL] [Abstract][Full Text] [Related]
15. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
[TBL] [Abstract][Full Text] [Related]
16. Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?
Kim JS; Ryu JG; Kim JW; Hwang EC; Jung SI; Kang TW; Kwon D; Park K
Int Braz J Urol; 2015; 41(2):258-64. PubMed ID: 26005966
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.
Rodriguez JF; Eggener SE
Radiol Clin North Am; 2018 Mar; 56(2):187-196. PubMed ID: 29420975
[TBL] [Abstract][Full Text] [Related]
18. [Clinical value of prostate specific antigen screening in early detection of prostate cancer].
Hua LX; Qiao D; Song NH; Feng NH; Yang J; Zhang JX; Chen JG; Zhang W; Sui YG; Wu HF
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):705-9. PubMed ID: 20021870
[TBL] [Abstract][Full Text] [Related]
19. Reconsidering Prostate Cancer Screening.
Schmidt C
J Natl Cancer Inst; 2017 Jan; 109(1):1-2. PubMed ID: 28104781
[No Abstract] [Full Text] [Related]
20. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
[Next] [New Search]